- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06808997
Prospective Multicentre Mixed Methods Study to Explore Extubation Practices and Respiratory Outcomes in Extremely Preterm Neonates. (CERAINE)
Criteria and Reasons for Extubation and Non-extubation in Preterm Infants: A Mixed Methods Study Prospectively Exploring Extubation and Reintubation Practices in Extremely Preterm Infants, and Associated Respiratory Outcomes.
The purpose of this observational study is to learn about neonatologists' perceptions of extubation readiness and extubation and reintubation practices in extremely preterm infants in the first 2 weeks of life using prospective qualitative and quantitative data. Actual extubation readiness is defined as successful extubation, defined as no reintubation in the 7 days following extubation.
Key research questions are: How do clinicians assess extubation readiness in this population? Does this assessment correlate with actual extubation success? What factors (reasons, clinical status, ventilatory parameters) are associated with extubation readiness? Patients born before 28 weeks gestational age and admitted to the neonatal intensive care unit (NICU) within the first 24 hours are be included. The attending physician will complete a prospectively administered questionnaire with open-ended and multiple-choice questions to daily assess the decision and rationale for extubation or non-extubation of patients mechanically ventilated during the first 15 days of life.
Patient characteristics, respiratory outcomes, and mortality will be recorded until the end of hospitalisation and/or definitive weaning from any ventilatory support or supplemental oxygen.
Study Overview
Status
Detailed Description
With prolonged stays in the neonatal intensive care unit (NICU) and significant respiratory morbidity, respiratory management of the most premature newborns - born before 28 weeks gestational age (GA) - brings a number of challenges. Despite recommendations to give priority to non-invasive ventilation in cases of respiratory insufficiency, recent studies show that over 80% of these newborns receive mechanical ventilation (MV) at least once in their NICU course, most within the first week of life (100% if born at 23 SA, >90% at 24 and 25 SA, >80% at 26 and >70% at 27 weeks GA). Several studies have shown that a longer cumulative duration of MV is associated with a worse respiratory and neurodevelopmental prognosis in this population.
Early extubation is therefore recommended. However, extubation failures in patients born at these early stages of life are common and are per se associated with respiratory morbidity. Extubation failure is defined in the literature as reintubation within days of extubation.
A delay of 7 days after extubation has been identified as the time frame for capturing extubations related to respiratory causes. In a French study, using the SEPREVEN cohort for patients born before 27 weeks' GA, extubation failure at 3, 7 and 15 days concerned 25%, 33% and 50% of patients respectively. The decision to extubate a premature patient is a complex one, but contributes in part to the patient's outcome.
Shalish referred to the concept of "extubation readiness dilemma" to indicate the uncertainty surrounding the clinical features associated with successful extubation. Identifying a state for each patient that allows successful extubation, without reintubation in the following days, is most often based on ward routines in which assessments of the infant's respiratory capacity are taken into account. Medical literature doesn't provide recommendations on extubation criteria, and practices differ from one unit to another.
The aim of this study is to provide a detailed description of extubation practices and failures in several NICUs in France, based on a prospective collection of qualitative and mixed data.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Laurence Caeymaex, M.D, Ph.D
- Phone Number: 0033664095607
- Email: laurence.caeymaex@gmail.com
Study Contact Backup
- Name: Camille JUNG, MD PhD
- Phone Number: 0033157022268
- Email: camille.jung@chicreteil.fr
Study Locations
-
-
-
Amiens, France, 80054
- Completed
- Chu Amiens Sud
-
Bayonne, France, 64109
- Completed
- CH Côte Basque
-
Besançon, France, 25030
- Completed
- CHU de Besancon
-
Brest, France, 26609
- Recruiting
- Dr Jean-michel Roue
-
Contact:
- Jean-Michel ROUE, Dr
- Email: jean-michel.roue@chu-brest.fr
-
Principal Investigator:
- Jean-Michel Roue, Dr
-
Bron, France, 69677
- Completed
- Hopital Femme Mére Enfant - HFME
-
Cherbourg-Octeville, France, 50102
- Completed
- Centre Hospitalier Public du Cotentin
-
Clermont-Ferrand, France, 63 003
- Completed
- CH Estaing
-
Colombes, France, 92700
- Completed
- CHU Louis Mourier
-
Créteil, France, 94000
- Completed
- CHIC
-
Grenoble, France, 38700
- Completed
- CHU Grenoble Alpes _site nord
-
La Réunion, France, 97405
- Completed
- CHU Felix Guyon
-
Le Kremlin-Bicêtre, France, 94270
- Completed
- CHU Kremlin-Bicêtre
-
Le Mans, France, 72037
- Completed
- CH Le Mans
-
Lille, France, 75019
- Completed
- Chu Lille
-
Limoges, France, 87042
- Completed
- HME Limoges
-
Marseille, France, 13915
- Completed
- APHM_ Hôpital Nord
-
Meaux, France, 77104
- Completed
- GHEF- Site de MEAUX
-
Montreuil, France, 93105
- Completed
- CHI André Grégoire
-
Mulhouse, France, 68100
- Completed
- GHRMSA-Hopital Emile Muller
-
Nice, France, 06202
- Completed
- CHU Nice
-
Nîmes, France, 30000
- Completed
- Chu Nimes
-
Orléans, France, 45067
- Completed
- CH Orléans
-
Paris, France, 75019
- Completed
- CHU Robert Debré
-
Paris, France, 75743
- Completed
- CHU Necker
-
Paris, France, 75679
- Completed
- Chu Port Royal
-
Poissy, France, 78303
- Completed
- CHI Poissy - St Germain en LayE
-
Reims, France, 51100
- Completed
- CHU Reims
-
Rennes, France, 35203
- Completed
- CHU Rennes
-
Saint-Denis, France, 93205
- Completed
- CH General Delafontaine
-
Senlis, France, 60300
- Completed
- CH GHPSO
-
Troyes, France, 10000
- Completed
- CH Troyes
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Gestational age < 28 weeks of gestation
- Age at admission to the participating unit <24 hours
Exclusion Criteria:
- Parental opposition to their infant's clinical data collection
- Participation in a research protocol with potential impact on extubation and/or duration of mechanical ventilation
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Extremely Low Gestational Age Newborns (elgans)
No intervention. unique group.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reasons for non-extubation in case of MV in patients born before 28 wks GA in the first 15 days of life,
Time Frame: On a 12 hours basis from Day 0 to Day 2 of life, and on a dialy basis from Day 2 to Day 15 of life (according to the period the patient is on Mechanical Ventilation)
|
For each included patient who is intubated and mechanically ventilated during a period within his first 15 days of life, the reasons for non-extubation.
These are the reasons reported by the physician by answering a qualitative questionnaire with an open-ended question, and preexistent possible multiple choices.
|
On a 12 hours basis from Day 0 to Day 2 of life, and on a dialy basis from Day 2 to Day 15 of life (according to the period the patient is on Mechanical Ventilation)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Reported perceived extubation readiness in Extremely Low Gestational Age Neonates (ELGANs) born before 28weeks gestation and mechanically ventilated in a period within the first 15 days of life.
Time Frame: These data will be collected in case of Mechanical Ventilation every 48 hours between the Birthday and Day 2 of life and then every morning between Day 2 and Day 15 of life
|
Reported perceived extubation readiness in ELGANs born before 28weeks gestation and mechanically ventilated in a period within the first 15 days of life, defined as Reasons for extubation and ventilatory and clinical data,
|
These data will be collected in case of Mechanical Ventilation every 48 hours between the Birthday and Day 2 of life and then every morning between Day 2 and Day 15 of life
|
|
Occurrence of Extubation failure in ELGANs on Mechanical ventilation within the first 15 days of life.
Time Frame: These data will be collected in case of Mechanical Ventilation every 48 hours between the Birthday and Day 2 of life and then every morning between Day 2 and Day 15 of life
|
Occurrence of Extubation failure defined as reintubation in the 7 days after an extubation.
|
These data will be collected in case of Mechanical Ventilation every 48 hours between the Birthday and Day 2 of life and then every morning between Day 2 and Day 15 of life
|
|
Corrected gestational age on definitive discontinuation of MV, of Positive Pressure Non-Invasive Ventilation (NIV), of High Flow Nasal Cannula (HFNC) ventilation) and Low Flow Nasal Cannula Ventilation (LFNNC)
Time Frame: From the day of birth to 4 months of age.
|
Corrected gestational age on definitive discontinuation of MV, of Positive Pressure Non-Invasive Ventilation (NIV), of High Flow Nasal Cannula (HFNC) ventilation) and Low Flow Nasal Cannula Ventilation (LFNNC)
|
From the day of birth to 4 months of age.
|
|
Cumulative duration of mechanical ventilation (MV) during the NICU stay.
Time Frame: These data will be collected from the day of birth to the day of discharge from the NICU, up to maximum 4 months of age..
|
Sum of the days of mechanical ventilation during the NICU stay, collected prospectively.
|
These data will be collected from the day of birth to the day of discharge from the NICU, up to maximum 4 months of age..
|
|
The cumulative duration of any respiratory support
Time Frame: From the day of birth to the day of discharge from the hospital, up to maximum 4 months of age.
|
The cumulative duration of positive pressure Non-Invasive Ventilation (PPNIV) and High Flow Nasal Ventilation (HFNV), Low Flow Nasal Ventilation (LFNV) during the entire hospital stay
|
From the day of birth to the day of discharge from the hospital, up to maximum 4 months of age.
|
|
Duration of Mechanical Ventilation and Positive Pressure Non-Invasive Ventilation
Time Frame: From the day of birth to the day of discharge from the hospital, up to 4 months of age
|
Sum of the days of Mechanical Ventilation or positive pressure non invasive ventilation during the entire hospital stay
|
From the day of birth to the day of discharge from the hospital, up to 4 months of age
|
|
Bronchopulmonary dysplasia at 36 weeks corrected Gestational Age
Time Frame: At 36 weeks corrected gestational age
|
Bronchopulmonary dysplasia at 36 weeks corrected Gestational age defined as need for any type of ventilation (invasive or non-invasive) or low flow oxygen therapy at 36 weeks gestational age.
|
At 36 weeks corrected gestational age
|
|
Mortality
Time Frame: From the day of birth to the day of discharge from the hospital, maximum 5 months of age
|
Mortality before discharge from the hospital
|
From the day of birth to the day of discharge from the hospital, maximum 5 months of age
|
|
Length of stay in the Neonatal Intensive Care Unit (NICU)
Time Frame: From the day of birth to the day of discharge from the NICU, maximum 4 months of life
|
Length of stay in the NICU
|
From the day of birth to the day of discharge from the NICU, maximum 4 months of life
|
|
Factors involved in the perception of "too altered respiratory condition to be extubated"
Time Frame: From the day of birth to day 15 of life during the period on Mechanical Ventilation
|
Description of the reasons related to the respiratory system, clinical respiratory conditions (e;g.
apneas ....) and ventilatory settings (pressure, oxygen, ...) reported by the physician associated with a reported "too altered respiratory condition to be extubated" condition.
|
From the day of birth to day 15 of life during the period on Mechanical Ventilation
|
|
Clinician-reported Prognosis of extubation succes
Time Frame: From day of birth to day 15 of life during the period on Mechanical Ventilation
|
Physician-reported prognosis of extubation based on a 4 points scale (from 1 "unconfident" to 4 "very confident")
|
From day of birth to day 15 of life during the period on Mechanical Ventilation
|
|
Description of complications of intubation
Time Frame: from the day birth to the day discharge from the NICU, up to maximum 4 months of life
|
Description of a multiple choice of complications after each intubation : No complication, oropharyngeal lesion, cardiorespiratory arrest, severe intraventricular haemorraghe, contribution to patient's death. |
from the day birth to the day discharge from the NICU, up to maximum 4 months of life
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Description of unit practices (mechanical ventilation weaning protocol and/or extubation criteria in standard care)
Time Frame: From the date of enrollment to the date of the end of the inclusions, which means one year.
|
Description of unit practices (use of a Mechanical Ventilation weaning protocol and/or the use of extubation criteria in standard care)
|
From the date of enrollment to the date of the end of the inclusions, which means one year.
|
Collaborators and Investigators
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- CERAINE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Bronchopulmonary Dysplasia
-
Hospices Civils de LyonNot yet recruitingBronchopulmonary Dysplasia (BPD)
-
NICHD Neonatal Research NetworkEunice Kennedy Shriver National Institute of Child Health and Human Development...Not yet recruitingBronchopulmonary Dysplasia (BPD)
-
Khang NguyenNot yet recruitingBronchopulmonary Dysplasia (BPD) | Respiratory Distress Syndrome (RDS)United States
-
Institute of Health Information and Statistics...University Hospital Olomouc; General University Hospital, Prague; Institute for... and other collaboratorsRecruitingPulmonary Hypertension | BPD - Bronchopulmonary DysplasiaCzechia
-
Centre Hospitalier Intercommunal CreteilNot yet recruitingControls Born at Term | Premature With Dysplasia Bronchopulmonary | Premature Without Dysplasia Bronchopulmonary
-
Adel MohamedHealth Sciences Centre, Winnipeg, Manitoba; Mount Sinai Hospital, CanadaCompletedBronchopulmonary Dysplasia (BPD)Canada
-
The Children's Hospital of Zhejiang University...Recruiting
-
Xingwang ZhuHunan Provincial People's Hospital; First People's Hospital of Chenzhou; Kunming... and other collaboratorsNot yet recruitingBronchopulmonary Dysplasia (BPD) | Respiratory Distress Syndrome (& [Hyaline Membrane Disease])
-
Children's Hospital of Eastern OntarioThe Hospital for Sick Children; Hannover Medical School; MOUNT SINAI HOSPITAL; St... and other collaboratorsRecruitingLung Function | BPD - Bronchopulmonary DysplasiaCanada
-
Cynthia McEvoyUniversity of Florida; University of California, San Francisco; Thrasher Research... and other collaboratorsTerminatedBronchopulmonary Dysplasia (BPD)United States